Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
1,187 stocks in the Americas match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| PGEN | Precigen, Inc. | Healthcare | $2.65B | $7.42 | −3.82% | +34.18% |
| CDNA | CareDx, Inc. | Healthcare | $2.64B | $50.96 | −0.32% | +42.55% |
| SUPN | Supernus Pharmaceuticals, Inc. | Healthcare | $2.61B | $44.88 | −24.80% | −5.97% |
| RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | $2.61B | $26.44 | −33.72% | +1.77% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| PHVS | Pharvaris N.V. | Healthcare | $2.60B | $37.00 | −2.96% | +9.97% |
| BHVN | Biohaven Ltd. | Healthcare | $2.56B | $16.95 | −8.70% | +23.09% |
| TRVI | Trevi Therapeutics, Inc. | Healthcare | $2.55B | $17.92 | −11.37% | −2.77% |
| NEOG | Neogen Corporation | Healthcare | $2.54B | $11.70 | −8.95% | +27.31% |
| RAPP | Rapport Therapeutics, Inc. | Healthcare | $2.52B | $52.50 | −0.62% | +25.12% |
| NKTR | Nektar Therapeutics | Healthcare | $2.52B | $73.77 | −32.32% | +4.24% |
| BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | $2.51B | $9.83 | −12.39% | +0.92% |
| CURA.TO | Curaleaf Holdings, Inc. | Healthcare | $2.51B | 13.16 CAD | −22.22% | +8.58% |
| KOD | Kodiak Sciences Inc. | Healthcare | $2.48B | $39.33 | −17.79% | −2.38% |
| PBH | Prestige Consumer Healthcare Inc. | Healthcare | $2.47B | $52.15 | −26.62% | +0.83% |
| ATRC | AtriCure, Inc. | Healthcare | $2.45B | $48.17 | −3.43% | +21.18% |
| NUVB | Nuvation Bio Inc. | Healthcare | $2.44B | $6.96 | −28.62% | +4.04% |
| BHC | Bausch Health Companies Inc. | Healthcare | $2.43B | $6.51 | −18.63% | +44.03% |
| BHC.TO | Bausch Health Companies Inc. | Healthcare | $2.43B | 9.03 CAD | −18.50% | +41.09% |
| KLRA | Kailera Therapeutics, Inc. | Healthcare | $2.39B | $18.44 | −34.68% | +10.16% |
| OCUL | Ocular Therapeutix, Inc. | Healthcare | $2.37B | $10.77 | −34.49% | +27.46% |
| ALMR | Alamar Biosciences, Inc. | Healthcare | $2.36B | $34.08 | −11.57% | +37.92% |
| GRDN | Guardian Pharmacy Services, Inc. | Healthcare | $2.36B | $37.48 | −20.29% | −10.46% |
| UFPT | UFP Technologies, Inc. | Healthcare | $2.36B | $304.57 | −10.08% | +18.02% |
| HRMY | Harmony Biosciences Holdings, Inc. | Healthcare | $2.31B | $39.66 | −2.96% | +10.88% |
| BFLY | Butterfly Network, Inc. | Healthcare | $2.30B | $8.64 | −14.03% | +20.50% |
| COAG | Hemab Therapeutics Holdings, Inc. | Healthcare | $2.30B | $49.19 | −11.24% | +4.08% |
| MLYS | Mineralys Therapeutics, Inc. | Healthcare | $2.28B | $25.89 | −45.67% | −3.93% |
| NEO | NeoGenomics, Inc. | Healthcare | $2.26B | $17.37 | −0.46% | +29.63% |
| NBTX | Nanobiotix S.A. | Healthcare | $2.26B | $44.50 | −22.12% | +17.66% |
| CLOV | Clover Health Investments, Corp. | Healthcare | $2.26B | $4.25 | −23.97% | −1.96% |
| ADUS | Addus HomeCare Corporation | Healthcare | $2.25B | $120.71 | −3.00% | +1.25% |
| URGN | UroGen Pharma Ltd. | Healthcare | $2.25B | $45.94 | −9.58% | +12.38% |
| MESO | Mesoblast Limited | Healthcare | $2.23B | $16.84 | −21.67% | +16.54% |
| PVLA | Palvella Therapeutics, Inc. | Healthcare | $2.22B | $154.33 | −4.37% | +8.04% |
| AUPH | Aurinia Pharmaceuticals Inc. | Healthcare | $2.20B | $16.54 | −14.08% | +10.56% |
| MD | Pediatrix Medical Group, Inc. | Healthcare | $2.19B | $26.95 | −3.54% | +0.34% |
| XRAY | DENTSPLY SIRONA Inc. | Healthcare | $2.18B | $10.93 | −26.45% | −18.98% |
| EXE.TO | Extendicare Inc. | Healthcare | $2.18B | 31.68 CAD | −19.06% | −17.40% |
| VCEL | Vericel Corporation | Healthcare | $2.17B | $42.44 | −13.95% | −9.14% |
| ADMA | ADMA Biologics, Inc. | Healthcare | $2.16B | $9.63 | −52.93% | +9.56% |
| ZBIO | Zenas BioPharma, Inc. | Healthcare | $2.15B | $33.04 | −25.92% | +2.32% |
| ESTA | Establishment Labs Holdings Inc. | Healthcare | $2.15B | $72.45 | −25.76% | −21.16% |
| CLOV34.SA | Clover Health Investments, Corp. | Healthcare | $2.15B | 20.84 BRL | −25.97% | −7.01% |
| HCM | HUTCHMED (China) Limited | Healthcare | $2.15B | $12.35 | −32.51% | +10.27% |
| STOK | Stoke Therapeutics, Inc. | Healthcare | $2.14B | $33.09 | −17.73% | +12.59% |
| XNCR | Xencor, Inc. Common Stock | Healthcare | $2.11B | $28.44 | −7.09% | +42.41% |
| ZYME | Zymeworks Inc. | Healthcare | $2.10B | $29.31 | −4.29% | +29.61% |
| NVCR | NovoCure Limited | Healthcare | $2.08B | $17.89 | −16.60% | +9.69% |
| GENB | Generate Biomedicines, Inc. | Healthcare | $2.07B | $16.14 | −28.80% | +22.83% |
| SRPT | Sarepta Therapeutics, Inc. | Healthcare | $2.06B | $19.46 | −23.14% | +26.12% |
| PRGO | Perrigo Company plc | Healthcare | $2.05B | $14.76 | −40.02% | +43.30% |
| SEM | Select Medical Holdings Corp | Healthcare | $2.05B | $16.51 | −2.83% | −0.12% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | Healthcare | $2.03B | $33.99 | −26.11% | −5.56% |
| CMPS | COMPASS Pathways plc | Healthcare | $2.02B | $14.61 | −5.13% | +34.65% |
| GHRS | GH Research PLC | Healthcare | $1.99B | $29.01 | −7.73% | +3.76% |
| PIII | P3 Health Partners Inc. | Healthcare | $1.98B | $9.92 | −41.27% | −5.70% |
| PGNY | Progyny, Inc. | Healthcare | $1.98B | $26.37 | −20.25% | −14.27% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | Healthcare | $1.98B | 4.82 BRL | −27.74% | +24.55% |
| FLRY3.SA | Fleury S.A. | Healthcare | $1.97B | 18.66 BRL | −5.42% | +9.38% |
| TSHA | Taysha Gene Therapies, Inc. | Healthcare | $1.96B | $6.02 | −17.53% | +10.26% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.